The rupee appreciated by 1 paisa to 84.06 against the US dollar in early trade on Monday, influenced by persistent foreign fund outflows, a muted trend in domestic equities, and rising crude oil prices. This follows a relatively quiet week due to Diwali celebrations and ongoing intervention by the Reserve Bank of India.
Posts tagged All News
Gensol Engineering zooms over 5% on securing Rs 780 crore solar PV project (04-11-2024)
Gensol Engineering share price surged 5.45 per cent at Rs 860 a piece on the BSE in Monday’s intraday deals
Trump or Kamala Harris? Get ready for a nail-biting week: Charu Chanana (04-11-2024)
With the US elections underway, early ballots indicate a tight race between Kamala Harris and Donald Trump. Markets had been betting on a Trump victory, but recent shifts in traditionally Republican states suggest growing support for Harris. Financial markets may react differently depending on the election outcome, influencing the US dollar and sector-specific stocks.
Globus Spirits (04-11-2024)
Totally agree to your point that globus will trade at cheaper valuation in comparison to its peers. More than valuation re-rating, a cyclical reversion is what I am looking at here. Higher contribution from consumer business is something that may happen. Company is doing well on the sales front. So raw material prices has been the major spoiler.
We may softening of food prices this year, which should aid margins.
Estimated rice production for the year in India is expected to increase by 3 million tons
estimated production india 2024.pdf (458.2 KB)
Also, find attached USDA estimates
rcs-24i.pdf (1.2 MB)
Siemens share price 0.69 per cent (04-11-2024)
A total of 1,568 shares changed hands on the counter till 10:24AM (IST).
Stock market update: Nifty Pharma index 1.07% in a weak market (04-11-2024)
The Nifty Pharma index was trading 1.07 per cent at 22562.65.
Hariom Pipes Ltd: A Capex Play! (04-11-2024)
Company has uploaded the earnings call transcript today. Few notable points from there:
- Margin and EBITDA guidance
CFO is hinting towards margins to be closer to 13.5% in FY26 and hence EBITDA potential of 337 crores in FY26
(At the same time highlighting that “But our vision is much more better, much more bigger than that”)
So maybe 13.5% is a conservative guidance on margins for FY26?
- EPS guidance assuming dilution of due to potential ~700 crore fund raise.
- EPS expected for FY25 = ~30
- EPS expected for FY26 = ~40-43 | This assumes dilution of a certain % at a certain stock price.
We need to do some math on back calculating the implied dilution % in-built in this EPS of 40-43
-
a) No dilution scenario:
- 337 crore of FY26 EBITDA mentioned by CFO above
- 50 crores of depreciation
- 40 crores of interest cost
- = expected PBT of 247 crores.
- Assume a 27% tax rate
- and this gives us 180 crores of PAT.
- 3.1 crores total shares outstanding gives an approximate FY26 EPS of ~58
-
b) Dilution Scenario
If we apply an EPS of 41.5 (mid-point of dilution scenario), on 180 crores of PAT, this assumes total shares outstanding of 4.33 crores which means ~40% dilution on share count basisCurrent Market Cap is ~1800 crores and 40% dilution means a fund raise of 1800*0.4 = 720 crores. So, basically the 40-43 EPS for dilution scenario assumes (1) QIP happens at CMP and (2) the entire 700 cr is raised and (3) No interest cost savings by debt paydown from QIP money (4) No incremental revenue or profits from incremental fund raise.
PS: There seems to be a typo in the transcript. it should read Rs. 30 for FY25 (instead of FY24).
What do others think of this calculation? Please point out any mistakes that you see.
Sensex, Nifty fall nearly 1% on US election jitters, FII selling pressure (04-11-2024)
Sensex fell from its previous close of 79,724.12 to 78,975.99, a drop of 748.13 points or 0.94 per cent; Nifty opened slightly higher at 24,315.75 from its previous close of 24,304.35 but slid to 24,080.15, down 224.20 points or 0.92 per cent by 9.40 AM
Sensex tanks 942 pts, Nifty plunges below 24K (04-11-2024)
From the 30-share Sensex pack, Sun Pharma, Reliance Industries, Infosys, Tata Motors, Infosys, Titan, Maruti and NTPC were among the major laggards. Mahindra and Mahindra, Tech Mahindra, HCL Technologies and IndusInd Bank were the gainers.